BLOG.FRANKMS.COM: Category Archive for Clinical Trials

Patients to bear the burden?

CONFIRM: Second Positive Trial

Google MS News, 3/11 & 3/12

Google MS News 3-2

Tovaxin® (T cell vaccination) granted fast-track designation by FDA

Old Treatments, New Tricks: Multiple Sclerosis

Analysis: Why in an age of health cuts we need more government research

MS Trial Alert: Drug Study at NIH Recruiting People with Secondary-Progressive MS

Merck Dumps Cladribine

Cardiovascular Risks With Oral Fingolimod for Multiple Sclerosis

False hope and cold reality

Novartis Investigational Multiple Sclerosis Therapy Gilenia* (FTY720) Shown To Reduce Relapse Rates Regardless Of Treatment History

Trial of Low-Dose Naltrexone Finds Preliminary Benefit to Mental Health Quality of Life for People with MS

First Blinded Study of Venous Insufficiency Prevalence in Multiple Sclerosis Shows Promising Results

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Calendar

Category Archives

Recent Posts

  1. ASK...
    Wednesday, May 30, 2012
  2. Arthritis Foundation, Great Lakes
    Wednesday, May 30, 2012
  3. Friends
    Tuesday, May 29, 2012
  4. Change
    Tuesday, May 29, 2012
  5. HELANTISUBRON 7 (HS-7)
    Monday, May 28, 2012
  6. HC-7, The Legacy
    Monday, May 28, 2012
  7. TAPS
    Sunday, May 27, 2012
  8. Louisville, KY
    Sunday, May 27, 2012
  9. Clyde Lassen
    Saturday, May 26, 2012
  10. Michael Patrick Murphy
    Saturday, May 26, 2012

Recent Comments

  1. Doris on PCIP Changes
    5/10/2012
  2. Shirley on Ticketed
    5/6/2012
  3. Frank on Losing ACCESS Service
    4/30/2012
  4. Shirley on Losing ACCESS Service
    4/30/2012
  5. Frank on Losing ACCESS Service
    4/30/2012
  6. Sherie on Losing ACCESS Service
    4/30/2012
  7. Treatments for PML on Gilenya, Tysabri & PML
    4/19/2012
  8. Shirley on Guide Dog Meets Pluto
    3/12/2012
  9. Shirley on Fresno Hit and Split
    3/3/2012
  10. Shirley on 77 Year Old Driver Charged
    2/19/2012

Subscribe


Tag Cloud

Blog Software